Clinical Trials Browser

Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT06162559 2024-01-11

TRAIN-4

Phase 1 Recruiting

30 enrolled

Breast

Breast Neoplasms

NCT01300962 2023-12-04

Study of BKM120 or BYL719 and Capecitabine in Patients With Metastatic Breast Cancer

Phase 1 Completed

47 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT03364348 2022-10-19

4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer

Phase 1 Completed

18 enrolled 17 charts

Breast

Breast Neoplasms

NCT02562378 2022-02-23

THELMA

Phase 1 Completed

15 enrolled 39 charts

Breast

Breast Neoplasms

NCT03135171 2021-09-10

Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to Trastuzumab

Phase 1 Completed

11 enrolled

Breast

Breast Neoplasms

NCT02167854 2021-07-09

Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer

Phase 1 Completed

23 enrolled

Breast

Breast Neoplasms

NCT02152943 2020-12-19

Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients

Phase 1 Completed

37 enrolled

Breast

Breast Neoplasms

NCT03846583 2020-10-23

Tucatinib + Abemaciclib + Herceptin for HER2+ MBC

Phase 1 Withdrawn

Breast

Breast Neoplasms

NCT00085020 2020-08-03

GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/Neu

Phase 1 Completed

13 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00543504 2020-06-30

Bevacizumab in Multiple Phase I Combinations

Phase 1 Completed

343 enrolled

Advanced Cancer

NCT02060253 2018-06-14

Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer

Phase 1 Completed

9 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT02598427 2018-02-28

Intrathecal Pertuzumab and Trastuzumab in Patients With New Untreated Asymptomatic or Low Symptomatic Brain Metastasis in HER2 Positive Breast Cancer

Phase 1 Terminated

1 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT02593708 2017-11-17

Phase1 of Neratinib+Trastuzumab, Pertuzumab, Paclitaxel in Patients With Advanced Solid Tumors/HER2+

Phase 1 Terminated

6 enrolled

Other solid neoplasm

Solid Tumor

NCT01454804 2016-04-13

Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors

Phase 1 Completed

43 enrolled

Advanced Cancers

NCT01235897 2014-04-17

MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor Malignancies

Phase 1 Completed

17 enrolled 7 charts

Tumor-Agnostic

Neoplasms

NCT00014430 2013-03-14

Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer

Phase 1 Completed

13 enrolled

Breast

Breast Neoplasms

NCT00009997 2011-03-28

Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

Phase 1 Completed

Breast

Breast Neoplasms

NCT00199212 2011-02-24

PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2

Phase 1 Completed

19 enrolled

Breast

Breast Neoplasms

NCT00084513 2010-02-12

Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing Cancer

Phase 1 Completed

18 enrolled

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific